VEGFA |
P15692
|
vascular endothelial growth factor A
|
Signaling
|
2.4E-05 |
0.266 |
0.923 |
TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
THPO |
P40225
|
thrombopoietin
|
|
0.20 |
0.513 |
0.692 |
TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
TBC1D9 |
Q6ZT07
|
TBC1 domain family member 9
|
Enzyme
|
2.8E-05 |
0.399 |
0.846 |
SOAT1 |
P35610
|
sterol O-acyltransferase 1
|
Enzyme
|
7.4E-10 |
0.424 |
0.846 |
SF3B1 |
O75533
|
splicing factor 3b subunit 1
|
Nucleic acid binding
|
1.00 |
0.511 |
0.731 |
SETBP1 |
Q9Y6X0
|
SET binding protein 1
|
|
1.00 |
0.503 |
0.808 |
PRSS27 |
Q9BQR3
|
serine protease 27
|
Enzyme
|
8.0E-05 |
0.805 |
0.154 |
SCT |
P09683
|
secretin
|
|
1.4E-07 |
0.484 |
0.846 |
RUNX1 |
Q01196
|
RUNX family transcription factor 1
|
Transcription factor
|
0.65 |
0.425 |
0.808 |
RET |
P07949
|
ret proto-oncogene
|
Kinase
|
1.00 |
0.392 |
0.885 |
PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
NPM1 |
P06748
|
nucleophosmin 1
|
Chaperone
|
1.00 |
0.464 |
0.846 |
NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
MPL |
P40238
|
MPL proto-oncogene, thrombopoietin receptor
|
Receptor
|
4.1E-09 |
0.510 |
0.692 |
MECOM |
Q03112
|
MDS1 and EVI1 complex locus
|
|
1.00 |
0.513 |
0.731 |
KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
JARID2 |
Q92833
|
jumonji and AT-rich interaction domain containing 2
|
Transcription factor
|
1.00 |
0.615 |
0.577 |
JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
IDH2 |
P48735
|
isocitrate dehydrogenase (NADP(+)) 2
|
|
0.88 |
0.434 |
0.808 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
IL3 |
P08700
|
interleukin 3
|
|
2.6E-09 |
0.489 |
0.731 |
INPP5D |
Q92835
|
inositol polyphosphate-5-phosphatase D
|
|
0.97 |
0.558 |
0.731 |